Fundraising Fox

OncoVerity

Aurora, US · Founded 2022 · Delaware corporation · 3 known investors

Founders & leadership

MC
Massimiliano ColaoChief Executive Officer
CS
Clayton SmithChief Medical Officer
SV
Steven VanNurdenExecutive

Board

AL
Arjen LemmenBoard director
PV
Petra Van VlierbergheBoard director
KMKimberly Muller
Kimberly MullerinBoard directorGeneral Partner at CU Healthcare Innovation Fund
SH
Steven HessBoard director

Investors · 3

Also in the syndicate · 2

argenxleadRefinedSciencelead

Reported raises · per SEC filings

Form D private placements

$18M disclosed across 2 rounds · 2022–2024

$14MraisedDec 2024 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Massimiliano ColaoDirector, Executive Officer
  • Arjen LemmenDirector
  • Petra Van VlierbergheDirector
  • Kimberly MullerDirector
  • Steven HessDirector
  • Clayton SmithExecutive Officer
Offering amount
$42M
Amount sold
$14M
First sale
Nov 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$4MraisedAug 2022 · 2 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven VanNurdenExecutive Officer, Director
  • Arjen LemmenDirector
  • Petra Van VlierbergheDirector
  • Steven HessDirector
Offering amount
$30M
Amount sold
$4M
First sale
Jul 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

Who are OncoVerity's investors?
OncoVerity's investors include CU Healthcare Innovation Fund.
How much funding has OncoVerity raised?
OncoVerity has disclosed $18M raised across 2 rounds.
Where is OncoVerity headquartered?
OncoVerity is headquartered in Aurora, US.